KUALA LUMPUR, Malaysia, July 22, 2025 /PRNewswire/ — Dr. Dzulkefly Ahmad, Minister of Health of Malaysia, visited the GuidelineX exhibition at HIMSS APAC 2025, where he engaged in comprehensive discussions on AI-powered clinical decision support systems (CDSS). The minister examined the practical applications of GuidelineX’s technology, which has supported 61 million inpatient visits and facilitated 1.4 billion outpatient visits annually across China, representing 25% and 33% of the national patient visits to hospitals, respectively.

Dr. Ahmad noted Malaysia’s ongoing efforts in digital health and took interest in GuidelineX’s reported outcomes, including a 46% reduction in hospital-acquired venous thromboembolism (HA-VTE) rates through AI-based alerting systems. Notably, GuidelineX’s AI  screened 10,233 individuals for Fabry disease within three months, efficiently identifying five confirmed cases and two individuals with GLA gene VUS, showcasing the tremendous potential of AI-CDSS in advancing early detection and population health strategies. "To succeed, we must look both inward and outward," stated Dr. Ahmad, highlighting that digital health transformation involves "more than just deploying systems – it requires a holistic approach to innovation and patient care."

Malaysia’s Minister of Health, Dr. Dzulkefly Ahmad, Visited the GuidelineX Booth.Malaysia’s Minister of Health, Dr. Dzulkefly Ahmad, Visited the GuidelineX Booth.

As a leading AI clinical adoption provider in Asia, GuidelineX offers next-generation, cloud-native solutions that have been implemented in 1,061 large hospitals by the end of 2024, including 50% of the country’s top 100 major hospitals. Dr. Jenny Shao, Chief Medical Officer of GuidelineX, presented the applications of AI in chronic disease management and oncology clinical pathways, to which the minister responded with recognition of the significant potential that AI holds for enhancing clinical healthcare.

GuidelineX positions AI as an intelligent and specialized assistant deeply integrated into clinical workflows, rather than a rigid tool requiring physician adaptation. This philosophy has driven its product ecosystem to deliver actionable clinical AI recommendations adopted 1 billion times annually by clinicians worldwide. The Minister expressed profound agreement with this product vision during the demonstration.

Media Contact: 

Xuan Hua+86-18813160136huaxuan@guidelinex.com

Source link

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network
You May Also Like

Infinitus Highlights Modernizing Traditional Prescriptions at ICMCM

GUANGZHOU, China, Aug. 20, 2024 /PRNewswire/ — Recently, the highly-anticipated 23rd International…

Everest Medicines Announces Positive Results of Complete Chinese Subpopulation Data from the NEFECON® Global Phase 3 NefIgArd Clinical Trial Published in "Kidney 360" Magazine

SHANGHAI, Oct. 22, 2024 /PRNewswire/ — Everest Medicines (HKEX 1952.HK, "Everest", or…

UDexreal released Game-changing VR Gloves in the Consumer Space

LAS VEGAS, Jan. 6, 2025 /PRNewswire/ — With unmatched 21 jolt angles…